GlassScriptPhysician profile
Gordon Kusi
NPI 1457782054
$2,041.24
in general payments reported to CMS, 2019-2025
9 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $217 · 2023: $666 · 2024: $626 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $516.52 | 2021-2025 | |
| Lundbeck LLC | $406.56 | 2021-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $355.73 | 2021-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Indivior INC. | $257.05 | 2022-2024 | Perseris, Sublocade |
| Teva Pharmaceuticals USA, INC. | $217.40 | 2022-2025 | Uzedy |
| Alkermes, INC. | $134.05 | 2021-2025 | Aristada, Lybalvi, Vivitrol |
| Janssen Pharmaceuticals, INC | $127.64 | 2022-2025 | Invega Sustenna, Spravato |
| Tris Pharma INC | $13.58 | 2021 | |
| Bioxcel Therapeutics, INC. | $12.71 | 2023 | Igalmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Kusi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.